TY - JOUR T1 - The annual prognostic ability of FACED and E-FACED scores to predict mortality in patients with bronchiectasis JF - ERJ Open Research JO - erjor DO - 10.1183/23120541.00139-2017 VL - 4 IS - 1 SP - 00139-2017 AU - David de la Rosa Carrillo AU - Rodrigo Athanazio AU - Rosa Maria Girón Moreno AU - Luis Máiz Carro AU - Casilda Olveira AU - Javier de Gracia AU - Montserrat Vendrell AU - Concepción Prados Sánchez AU - Georgina Gramblicka AU - Monica Corso Pereira AU - Fernando Lundgren AU - Mara Fernandes De Figueiredo AU - Francisco Arancibia AU - Samia Rached AU - Miguel-Angel Martínez-Garcia Y1 - 2018/01/01 UR - http://openres.ersjournals.com/content/4/1/00139-2017.abstract N2 - Bronchiectasis is a disease defined by a permanent and usually progressive bronchial dilation associated with multiple exacerbations and decreased health-related quality of life [1–3]. Improvement in the current knowledge of this condition's pathophysiology has clearly highlighted its complex and heterogeneous profile, whose severity or prognosis cannot be defined using a single variable [4]. Accordingly, multidimensional scores including demographical, clinical, microbiological and radiological data have recently been developed and validated as useful tools to better evaluate the disease's severity and prognosis: FACED (forced expiratory volume in 1 s (FEV1), age, chronic colonisation by Pseudomonas aeruginosa, radiological extension and dyspnoea), E-FACED (FACED plus exacerbations) and the bronchiectasis severity index (BSI) [5–8].Both FACED and E-FACED scores have shown good short-term prognostic value for predicting mortality in bronchiectasis http://ow.ly/albl30i11bv ER -